Background Salivary duct carcinoma (SDC) is an aggressive subtype of salivary gland
cancer. Approximately half of SDC patients will develop recurrences or metastases …

Accurate diagnosis of salivary gland tumors can be challenging because of the many
diagnostic entities, the sometimes extensive morphologic overlap, and the rarity of most …

Background Among salivary gland malignancies, the prognosis of salivary duct carcinoma
(SDC) is assumed to be the poorest. However, because of its low incidence, reliable survival …

Introduction HER2, a member of the human epidermal growth factor (HER) family of
transmembrane tyrosine kinases, has been of considerable interest in oncology due to its …

Salivary duct carcinoma (SDC) is an aggressive salivary gland malignancy with poor
survival. Approximately 30% SDC harbor HER2 amplification and response to trastuzumab …

Salivary gland carcinomas are rare tumours and therapy strategies are less standardized
than in lung, gastric or breast cancer. Therapy is based on surgery, but not all carcinomas …

Salivary gland cancers represent a rare group of tumors composed by over 20 histological
subtypes. Initially treated as one single disease, its diagnosis, prognosis, and treatment are …

The aim of our study is to assess the relation of human epidermal growth factor receptor 2 or
HER2/neu with the development of salivary gland carcinomas and use of Herceptin in the …

Salivary duct carcinoma is a highly aggressive salivary gland malignancy that may be
misdiagnosed as high-grade mucoepidermoid carcinoma. We utilized tissue microarrays …

Background The purposes of this study were to describe the characteristics of a prospective
multicenter series of patients with salivary duct carcinoma and to investigate prognostic …